Spiriva
Product Images NDC 50090-4414

29 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 29 technical images submitted to the FDA as part of the official labeling for Spiriva (NDC 50090-4414). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Spiriva 01)

FDA Label Image

Figure 1 (Spiriva 02)

Figure 1 (Spiriva 02)
A line graph comparing FEV1 (lung function) over 12 hours between Spiriva (n=202) and placebo (n=179). Spiriva shows a higher FEV1 that peaks around 2 to 4 hours and gradually declines, while placebo remains lower and relatively stable over time.*
FDA Label Image

Figure 1 (Spiriva 03)

Figure 1 (Spiriva 03)
A line graph comparing FEV1 (L) over 12 hours between Spiriva and placebo groups. Spiriva group data points show a peak near 1.3 L around 2 hours, then a gradual decline; placebo remains near 1.05 L with little variation. X-axis is time in hours; Y-axis is FEV1 in liters.*
FDA Label Image

Figure 2 (Spiriva 04)

Figure 2 (Spiriva 04)
A line graph comparing FEV1 (L) over time in hours between Spiriva (n=153) and Ipratropium (n=72). Spiriva shows a higher increase in FEV1 over 8 hours compared to Ipratropium.*
FDA Label Image

Figure 2 (Spiriva 05)

Figure 2 (Spiriva 05)
A line chart comparing FEV1 (L) over time (hours) between Spiriva and Ipratropium. Spiriva shows a higher FEV1 improvement over 6 hours compared to Ipratropium, with data points and trend lines labeled by treatment group size (n=153 for Spiriva, n=72 for Ipratropium).*
FDA Label Image

Figure 3 (Spiriva 06)

Figure 3 (Spiriva 06)
A line graph comparing FEV1 (L) values over 48 months between two groups: Tiotropium (n=2494) and Control (n=2363). The graph shows FEV1 on the vertical axis and time in months on the horizontal axis, with Tiotropium group values represented by solid triangles and Control group values by solid squares with a dashed line.*
FDA Label Image

Figure (Spiriva 07)

Figure (Spiriva 07)
An instructional illustration showing a circle split diagonally by a line, with a face on the left side preparing to consume a capsule or pill held by a hand on the right side. The design suggests a warning or prohibition related to oral ingestion of the capsule.*
FDA Label Image

Figure (Spiriva 08)

FDA Label Image

Figure (Spiriva 09)

Figure (Spiriva 09)
An instructional illustration showing a profile view of a person's open mouth on the left and a hand holding a capsule on the right. A diagonal line separates the two sides, indicating not to swallow the capsule whole.*
FDA Label Image

Figure A (Spiriva 10)

Figure A (Spiriva 10)
An instructional line drawing showing a hand holding a Spiriva inhaler device with numbered parts. The illustration highlights key components including the mouthpiece cover, the mouthpiece itself, and other structural elements relevant to its use.*
FDA Label Image

Figure B (Spiriva 11)

Figure B (Spiriva 11)
An illustration showing two hands holding and separating individual blister cards from a larger strip of Spiriva inhalation capsules packaging. The cards display the Spiriva brand name and identifying information on each capsule segment.*
FDA Label Image

Figure C (Spiriva 12)

Figure C (Spiriva 12)
An illustration showing a capsule labeled "TI 01" with an arrow pointing to the powder inside. The text states "Amount of powder in the SPIRIVA capsule," indicating the quantity of powder contained in the Spiriva capsule.*
FDA Label Image

Figure D (Spiriva 13)

Figure D (Spiriva 13)
An instructional illustration showing a hand holding a round Spiriva inhaler device. The thumb is positioned to press on the side of the inhaler, indicated by a right-pointing arrow, suggesting how to activate or use the device.*
FDA Label Image

Figure E (Spiriva 14)

Figure E (Spiriva 14)
Instructional illustration showing hands assembling or preparing a Spiriva inhaler device by positioning or twisting parts as indicated by arrows. The image demonstrates a step in the use or setup of the inhaler.*
FDA Label Image

Figure F (Spiriva 15)

Figure F (Spiriva 15)
An instructional illustration showing two hands opening a Spiriva device by twisting the cap with one hand while holding the device body with the other. Arrows indicate the twisting direction needed to open the device.*
FDA Label Image

Figure G (Spiriva 16)

Figure G (Spiriva 16)
An instructional illustration showing hands peeling two separate single-dose blisters from a strip of Spiriva capsules. The image demonstrates proper handling of the medication packaging for Spiriva, labeled from A-S Medication Solutions.*
FDA Label Image

Figure H (Spiriva 17)

Figure H (Spiriva 17)
An instructional illustration showing steps to peel back a label from the packaging. The image includes close-ups highlighting the label text for Spiriva by A-S Medication Solutions, emphasizing the action of peeling back the label for viewing or use.*
FDA Label Image

Figure I (Spiriva 18)

Figure I (Spiriva 18)
An instructional diagram showing a hand opening the top of a Spiriva inhaler device and a drop being placed into the center of the opened mouthpiece, indicated by a downward arrow. This image likely demonstrates a step for using or preparing the Spiriva inhaler.*
FDA Label Image

Figure J (Spiriva 19)

Figure J (Spiriva 19)
An instructional illustration showing hands handling the Spiriva inhalation device. The image highlights inserting or adjusting a component on the device with a finger pointing to the specific part, emphasizing proper assembly or usage.*
FDA Label Image

Figure K (Spiriva 20)

Figure K (Spiriva 20)
Instructional illustration showing how to hold and open the Spiriva inhaler device. The image depicts a hand holding the inhaler, with arrows indicating the motion needed to open or prepare the device for use.*
FDA Label Image

Figure L (Spiriva 21)

Figure L (Spiriva 21)
An illustration showing a side profile of a person's face exhaling a spray or mist, indicated by an arrow pointing forward from the mouth. The graphic likely demonstrates correct inhalation or administration technique for a medication like Spiriva.*
FDA Label Image

Figure M (Spiriva 22)

Figure M (Spiriva 22)
An instructional illustration showing a person holding a Spiriva inhaler near their mouth and preparing to inhale the medication, with an arrow indicating the direction of inhalation.*
FDA Label Image

Figure N (Spiriva 23)

Figure N (Spiriva 23)
An instructional diagram shows a side profile of a person's mouth exhaling a spray or mist, indicated by a dense cloud with an arrow pointing outward, illustrating proper inhalation technique likely related to the Spiriva medication.*
FDA Label Image

Figure O (Spiriva 24)

Figure O (Spiriva 24)
An instructional illustration showing a person using an inhaler device. The depiction focuses on the mouthpiece being placed in the mouth, indicating the direction for inhalation marked by an arrow pointing outward from the device.*
FDA Label Image

Figure P (Spiriva 25)

Figure P (Spiriva 25)
An instructional illustration showing a hand holding a Spiriva inhaler device, with arrows indicating a sliding or pressing motion on the inhaler mechanism. The image visually guides how to operate the device.*
FDA Label Image

Figure Q (Spiriva 26)

Figure Q (Spiriva 26)
An instructional illustration showing a hand holding a round, egg-shaped device with an oval button or window on its front and two black arrows pointing downward beneath it. The image likely demonstrates how to operate or handle the device associated with Spiriva by A-S Medication Solutions.*
FDA Label Image

Figure R (Spiriva 27)

Figure R (Spiriva 27)
An instructional illustration showing a hand cleaning a Spiriva inhaler device by rinsing it under running water from a faucet. The image emphasizes careful maintenance of the device with an arrow indicating the cleaning action on the inhaler mouthpiece.*
FDA Label Image

Figure (Spiriva 28)

FDA Label Image

Label Image (Lbl500904414)

Label Image (Lbl500904414)
Spiriva Handihaler 18 mcg capsules package label from A-S Medication Solutions. The label includes the NDC 50090-4414-0, product number 6896-0, and specifies 90 capsules per carton in 9 blister cards with 10 capsules each. It includes storage instructions and dosage reference to a package insert.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.